Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tongling Jieya Biologic Technology
301108
5
Nantong Jiangtian Chemical
300927
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||||||
Cash flow from continuing operating activities | -50.00%84.15M | -46.67%70.12M | -106.68%-7.48M | 1,607.69%470.6M | 58.72M | 168.3M | 131.47M | 112.11M | -31.21M |
Net income from continuing operations | -229.86%-9.57M | -230.08%-11.68M | -505.63%-12.55M | -88.37%5.82M | ---13.62M | --7.37M | --8.98M | --3.09M | --50.08M |
Operating gains losses | -166.52%-2.03M | -12,773.46%-544.81K | 131.25%390.79K | -99.40%14.27K | ---3.2M | --3.05M | ---4.23K | --168.99K | --2.38M |
Depreciation and amortization | 18.22%849.73K | 29.95%866.23K | 52.63%924.46K | 95.14%2.78M | --787.43K | --718.77K | --666.58K | --605.7K | --1.42M |
Deferred tax | -112.31%-2.55M | -103.43%-2.02M | -0.63%-1.06M | 80.04%-1.08M | --2.16M | ---1.2M | ---990.97K | ---1.05M | ---5.43M |
Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.41M |
Change In working capital | -39.29%92.1M | -34.78%75.02M | -107.08%-7.1M | 501.14%433.33M | --66.2M | --151.71M | --115.03M | --100.39M | ---108.02M |
-Change in receivables | -552.43%-71.5M | -10.83%-29.66M | -66.40%-27.62M | -1,766.08%-26.01M | --1.55M | --15.8M | ---26.76M | ---16.6M | --1.56M |
-Change in prepaid assets | -449.47%-15.25M | 316.50%15.03M | -500.92%-9.58M | -70.21%-27.62M | ---30.84M | ---2.78M | --3.61M | --2.39M | ---16.23M |
-Change in payables and accrued expense | -75.04%6.36M | 138.80%3.23M | 88.75%-1.94M | 85.52%-13.75M | ---13.7M | --25.47M | ---8.32M | ---17.21M | ---94.98M |
-Change in other current assets | -57.47%-15.9M | -324.39%-71.34M | -95.16%-12.89M | -1,430.48%-45.86M | ---12.35M | ---10.1M | ---16.81M | ---6.6M | ---3M |
-Change in other current liabilities | -649.96%-548.86K | 759.51%4.2M | -175.46%-1.07M | -69.16%929.59K | --225.74K | ---73.19K | ---637.23K | --1.41M | --3.01M |
-Change in other working capital | 53.13%188.93M | -6.34%153.55M | -66.43%45.99M | 33,949.50%545.64M | --121.32M | --123.38M | --163.94M | --137M | --1.6M |
Cash from discontinued investing activities | |||||||||
Operating cash flow | -50.00%84.15M | -46.67%70.12M | -106.68%-7.48M | 1,607.69%470.6M | --58.72M | --168.3M | --131.47M | --112.11M | ---31.21M |
Investing cash flow | |||||||||
Cash flow from continuing investing activities | 49.66%-980.43K | 36.05%-281.43K | 72.98%-689.59K | 69.04%-10.04M | -5.1M | -1.95M | -440.09K | -2.55M | -32.43M |
Net PPE purchase and sale | 49.66%-980.43K | 36.05%-281.43K | 31.59%-689.59K | 85.60%-4.54M | ---1.15M | ---1.95M | ---440.09K | ---1.01M | ---31.55M |
Net business purchase and sale | --0 | --0 | --0 | -4,934.55%-5.5M | ---3.95M | --0 | --0 | ---1.54M | ---109.16K |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---769.46K |
Cash from discontinued investing activities | |||||||||
Investing cash flow | 49.66%-980.43K | 36.05%-281.43K | 72.98%-689.59K | 69.04%-10.04M | ---5.1M | ---1.95M | ---440.09K | ---2.55M | ---32.43M |
Financing cash flow | |||||||||
Cash flow from continuing financing activities | 100.00%291 | 0 | 40.35M | -28.23%12.84M | 0 | -7.16M | 20M | 0 | 17.89M |
Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---10.84M |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --3.45K |
Net preferred stock issuance | --0 | --0 | --40.3M | 6.82%20M | --0 | --0 | --20M | --0 | --18.72M |
Proceeds from stock option exercised by employees | --291 | --0 | --48.7K | --0 | --0 | --0 | --0 | --0 | --10M |
Net other financing activities | ---- | ---- | ---- | ---7.16M | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | |||||||||
Financing cash flow | 100.00%291 | --0 | --40.35M | -28.23%12.84M | --0 | ---7.16M | --20M | --0 | --17.89M |
Net cash flow | |||||||||
Beginning cash position | 41.10%1.09B | 62.30%1.02B | 91.81%994.14M | -8.99%518.3M | --932.14M | --774.89M | --631.1M | --518.3M | --569.5M |
Current changes in cash | -47.75%83.17M | -53.76%69.84M | -70.64%32.17M | 1,134.63%473.39M | --53.62M | --159.19M | --151.03M | --109.56M | ---45.75M |
Effect of exchange rate changes | 292.78%3.73M | 90.37%-697.15K | -163.79%-2.07M | 145.00%2.45M | --8.39M | ---1.94M | ---7.24M | --3.24M | ---5.45M |
End cash Position | 26.62%1.18B | 41.10%1.09B | 62.30%1.02B | 91.81%994.14M | --994.14M | --932.14M | --774.89M | --631.1M | --518.3M |
Free cash flow | -50.00%83.17M | -46.70%69.84M | -107.36%-8.17M | 842.55%466.05M | --57.57M | --166.35M | --131.03M | --111.11M | ---62.76M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |